The Immunogenicity of the C Fragment of Tetanus Neurotoxin in Production of Tetanus Antitoxin

A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results

(2017) Wanying Xu et al.   PLoS One

Establishment of an equine tetanus antitoxin reference standard for veterinary use in Japan

(2016) Fumiya Hirano et al.   BIOLOGICALS

Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus Monkeys

(2016) Rui Yu et al.   Toxins

Key protection factors against tetanus: Anti-tetanus toxin antibody affinity and its ability to prevent tetanus toxin – ganglioside interaction

(2015) Ivana Lukić et al.   TOXICON

Response to “Protective effect of tetanus antibodies”

(2014) Kristan E. Vollman et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

Antitoxins for diphtheria and tetanus decline more slowly after vaccination with DTwP than with DTaP: A study in a Chinese population

(2014) Yuyan Wu et al.   VACCINE

Single-reagent one-step procedures for the purification of ovine IgG, F(ab′)2 and Fab antivenoms by caprylic acid

(2013) Ibrahim Al-Abdulla et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C

(2013) Mehdi Yousefi et al.   Journal of Immunotoxicology

A Conformational Change of C Fragment of Tetanus Neurotoxin Reduces Its Ganglioside-Binding Activity but Does Not Destroy Its Immunogenicity

(2011) Rui Yu et al.   Clinical and Vaccine Immunology

Enhanced expression of soluble recombinant tetanus neurotoxin Hc in Escherichia coli as a tetanus vaccine candidate

(2010) Rui Yu et al.   IMMUNOBIOLOGY